ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Interventional Cardiology

Top Interventional Cardiology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID MONTGOMERY MD

Interventional Cardiology

10,742

$807K

1042
982 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$75
Average prescription price

Avg: $90

CHARLES MAROTTA MD

Interventional Cardiology

8,390

$1.05M

623
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 33%

$125
Average prescription price

Avg: $90

KEASHAVA SHIVASHANKAR MD

Interventional Cardiology

6,652

$428K

316
265 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$64
Average prescription price

Avg: $90

HOWARD NOVECK M.D.

Interventional Cardiology

6,578

$708K

528
487 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 33%

$108
Average prescription price

Avg: $90

VARINDER SINGH MD

Interventional Cardiology

6,084

$486K

330
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 33%

$80
Average prescription price

Avg: $90

WILLIAM LEE MD

Interventional Cardiology

6,072

$441K

688
658 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 33%

$73
Average prescription price

Avg: $90

DINESH SINGAL M.D.

Interventional Cardiology

5,890

$407K

463
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$69
Average prescription price

Avg: $90

MARCUS WILLIAMS

Interventional Cardiology

5,523

$452K

617
586 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 33%

$82
Average prescription price

Avg: $90

OLUKAYODE OLADEJI MD

Interventional Cardiology

5,314

$471K

386
335 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 33%

$89
Average prescription price

Avg: $90

LEONARDO DIVAGNO MD

Interventional Cardiology

5,039

$378K

382
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 33%

$75
Average prescription price

Avg: $90

PUNEET SAHGAL M.D.

Interventional Cardiology

4,891

$349K

321
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$71
Average prescription price

Avg: $90

JAMES CLIFFORD MD

Interventional Cardiology

4,757

$365K

257
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 33%

$77
Average prescription price

Avg: $90

MARK BLUM MD

Interventional Cardiology

4,527

$488K

436
400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 33%

$108
Average prescription price

Avg: $90

THOMAS KOMOROWSKI M.D.

Interventional Cardiology

4,425

$427K

523
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$96
Average prescription price

Avg: $90

GERALD CIOCE M.D.

Interventional Cardiology

3,923

$284K

377
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$72
Average prescription price

Avg: $90

MATT BACH MD

Interventional Cardiology

3,817

$445K

484
455 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 33%

$116
Average prescription price

Avg: $90

TED GUTOWSKI M.D.

Interventional Cardiology

3,795

$430K

480
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 33%

$113
Average prescription price

Avg: $90

NAVIN BUDHWANI MD

Interventional Cardiology

3,779

$356K

423
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 33%

$94
Average prescription price

Avg: $90

PEDRO ESCANDON M.D.

Interventional Cardiology

3,748

$393K

369
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 33%

$105
Average prescription price

Avg: $90

JOHN COSMI MD

Interventional Cardiology

3,613

$290K

296
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 33%

$80
Average prescription price

Avg: $90

STEPHEN ANGELI MD

Interventional Cardiology

3,605

$241K

369
351 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 33%

$67
Average prescription price

Avg: $90

NELSON LAMARCHE M.D.

Interventional Cardiology

3,569

$348K

386
365 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 33%

$98
Average prescription price

Avg: $90

DAVID FREILICH MD

Interventional Cardiology

3,504

$375K

311
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 33%

$107
Average prescription price

Avg: $90

JAY STONE MD

Interventional Cardiology

3,441

$617K

670
628 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 33%

$179
Average prescription price

Avg: $90

EVAN SEHGAL MD

Interventional Cardiology

3,319

$339K

344
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 33%

$102
Average prescription price

Avg: $90

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank